Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.
Hathaway JT, Shah MP, Hathaway DB, Zekavat SM, Krasniqi D, Gittinger JW Jr, Cestari D, Mallery R, Abbasi B, Bouffard M, Chwalisz BK, Estrela T, Rizzo JF 3rd.
JAMA Ophthalmol. 2024 Aug 1;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296.
Wolfram Syndrome: Diagnosis, Management, and Treatment.
Urano F.
Curr Diab Rep. 2016 Jan;16(1):6. doi: 10.1007/s11892-015-0702-6.
Mitochondrial diseases.
Schapira AH.
Lancet. 2012 May 12;379(9828):1825-34. doi: 10.1016/S0140-6736(11)61305-6. Epub 2012 Apr 5.
Mitochondrial biogenesis: pharmacological approaches.
Valero T.
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy.
Cai CX, Hribar M, Baxter S, Goetz K, Swaminathan SS, Flowers A, Brown EN, Toy B, Xu B, Chen J, Chen A, Wang S, Lee C, Leng T, Ehrlich JR, Barkmeier A, Armbrust KR, Boland MV, Dorr D, Boyce D, Alshammari T, Swerdel J, Suchard MA, Schuemie M, Bu F, Sena AG, Hripcsak G, Nishimura A, Nagy P, Falconer T, DuVall SL, Matheny M, Viernes B, O'Brien W, Zhang L, Martin B, Westlund E, Mathioudakis N, Fan R, Wilcox A, Lai A, Stocking JC, Takkouche S, Lee LH, Xie Y, Humes I, McCoy DB, Adibuzzaman M, Areaux RG Jr, Rojas-Carabali W, Brash J, Lee DA, Weiskopf NG, Mawn L, Agrawal R, Morgan-Cooper H, Desai P, Ryan PB.
JAMA Ophthalmol. 2025 Apr 1;143(4):304-314. doi: 10.1001/jamaophthalmol.2024.6555.
Semaglutide: Double-edged Sword with Risks and Benefits.
Pillarisetti L, Agrawal DK.
Arch Intern Med Res. 2025;8(1):1-13. doi: 10.26502/aimr.0189. Epub 2025 Jan 10.
Semaglutide, type 2 diabetes, and the risk of nonarteritic anterior ischemic optic neuropathy.
Malerbi FK, Bertoluci MC.
Int J Retina Vitreous. 2025 Jan 22;11(1):8. doi: 10.1186/s40942-024-00622-9.
Nonarteritic Anterior Ischemic Optic Neuropathy and Semaglutide: What is This All About?
Singh AK, Kesavadev J, Tiwaskar M.
J Assoc Physicians India. 2024 Aug;72(8):11-12. doi: 10.59556/japi.72.0621.
Association between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy: A Multinational Population-Based Study.
Chou CC, Pan SY, Sheen YJ, Lin JF, Lin CH, Lin HJ, Wang IJ, Weng CH.
Ophthalmology. 2025 Apr;132(4):381-388. doi: 10.1016/j.ophtha.2024.10.030. Epub 2024 Nov 2.
Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes.
Grauslund J, Taha AA, Molander LD, Kawasaki R, Möller S, Højlund K, Stokholm L.
Int J Retina Vitreous. 2024 Dec 18;10(1):97. doi: 10.1186/s40942-024-00620-x.
